Histatins: antimicrobial peptides with therapeutic potential
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Histatins are a group of antimicrobial peptides, found in the saliva of man and some higher primates, which possess antifungal properties. Histatins bind to a receptor on the fungal cell membrane and enter the cytoplasm where they target the mitochondrion. They induce the non-lytic loss of ATP from actively respiring cells, which can induce cell death. In addition, they have been shown to disrupt the cell cycle and lead to the generation of reactive oxygen species. Their mode of action is distinct from those exhibited by the conventional azole and polyene drugs, hence histatins may have applications in controlling drug-resistant fungal infections. The possibility of utilising histatins for the control of fungal infections of the oral cavity is being actively pursued with the antifungal properties of topical histatin preparations and histatin-impregnated denture acrylic being evaluated. Initial clinical studies are encouraging, having demonstrated the safety and efficacy of histatin preparations in blocking the adherence of the yeast Candida albicans to denture acrylic, retarding plaque formation and reducing the severity of gingivitis. Histatins may represent a new generation of antimicrobial compounds for the treatment of oral fungal infections and have the advantage, compared with conventional antifungal agents, of being a normal component of human saliva with no apparent adverse effects on host tissues and having a mode of action distinct to azole and polyene antifungals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., & Troxler, R. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68522-9 · Cited by 652
The Cellular Target of Histatin 5 on Candida albicans Is the Energized Mitochondrion
Helmerhorst, E. J., Breeuwer, P., van 't Hof, W., Walgreen-Weterings, E., Oomen, L. C. J. M., Veerman, E. C. I., Amerongen, A. V. N., & Abee, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7286 · Cited by 283
Helmerhorst, E. J., Troxler, R. F., & Oppenheim, F. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141366998 · Cited by 251
Salivary Histatin 5 Induces Non-lytic Release of ATP fromCandida albicans Leading to Cell Death
Koshlukova, S. E., Lloyd, T. L., Araujo, M. W. B., & Edgerton, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18872 · Cited by 200
Candidacidal Activity of Salivary Histatins
Edgerton, M., Koshlukova, S. E., Lo, T. E., Chrzan, B. G., Straubinger, R. M., & Raj, P. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20438 · Cited by 198
Synthetic histatin analogues with broad-spectrum antimicrobial activity
HELMERHORST, E. J., HOF, W. V. '., VEERMAN, E. C. I., SIMOONS-SMIT, I., & AMERONGEN, A. V. N. (1997) · Biochemical Journal · doi:10.1042/bj3260039 · Cited by 183
Candida albicans Ssa1/2p Is the Cell Envelope Binding Protein for Human Salivary Histatin 5
Li, X. S., Reddy, M. S., Baev, D., & Edgerton, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300680200 · Cited by 167
Human Salivary Histatins: Promising Anti-Fungal Therapeutic Agents
Tsai, H., & Bobek, L. A. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090040601 · Cited by 154
Helmerhorst, E. J., Reijnders, I. M., Hof, W. V. ‘., Simoons-Smit, I. M., Veerman, E. C. I., & Amerongen, A. V. N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.702 · Cited by 145
Cited by
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
“Histatins bind to a receptor on the fungal cell membrane, enter the cytoplasm and induce the non-lytic loss of ATP from actively respiring cell”
BackgroundJenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
“variant of histatins, which are naturally occurring cationic peptides in saliva (124).”
BackgroundAntimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
“, 2008) thereby causing efflux of ATP, resulting in depletion of intracellular ATP contents and ultimately death (Tsai and Bobek, 1998; Rothstein et al., 2001; Kavanagh and Dowd, 2004).”
BackgroundInfluentialA Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
The Roles of Antimicrobial Peptides in Innate Host Defense
Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682325 · Cited by 642
“RNA, DNA synthesis) [63] to loss of ATP from actively respiring cells [64].”
Background
Metadata
- Authors
- Kavanagh, K., & Dowd, S.
- Affiliations
- National University of Ireland, Maynooth (IE)
- Corresponding author
- Kavanagh, Kevin
- ORCID
- Kavanagh, Kevin
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 56
- Issue
- 3
- Pages
- 285-289
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2082833445
- Cited by
- 223
- References
- 26
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 17 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 12 · 2019: 3 · 2018: 7 · 2017: 11 · 2016: 13 · 2015: 11 · 2014: 15 · 2013: 12 · 2012: 9
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Pharmacy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Maynooth University ePrints and eTheses Archive (Maynooth University) (acceptedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Keywords
- histatins, antimicrobial peptides, antifungal activity, saliva, Candida albicans, oral candidiasis, drug-resistant fungal infections, mitochondrial targeting, reactive oxygen species, gingivitis, plaque reduction, mechanism of action
- MeSH terms
- Histidine-Rich Glycoprotein, Animals, Anti-Bacterial Agents, Antifungal Agents, Forecasting, Humans, Peptides, Proteins, Saliva
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histatins: antimicrobial peptides with therapeutic potential. https://app.cochat.ai/papers/10.1211/0022357022971
- The paper
- Kavanagh, K., & Dowd, S. (2004). Histatins: antimicrobial peptides with therapeutic potential. Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/0022357022971
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.